Skip to content

ADMA Biologics ADMA Effective Income Tax Rate Reconciliation, Tax Credit, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Amount at other companies

ADMA Biologics logo
ADMA BiologicsADMA
$470.75K
Popular logo
PopularBPOP
$2.11M
Photronics logo
PhotronicsPLAB
$1.16M-10.8%
Minerals Technologies logo
Minerals TechnologiesMTX
$25K
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
$529.25K
Popular logo
PopularBPOP
$2.11M

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCredits.

The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's effective income tax rate reconciliation, tax credit, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's effective income tax rate reconciliation, tax credit, amount?
ADMA Biologics (ADMA) reported effective income tax rate reconciliation, tax credit, amount of $470.75K in Q4 2025.
What does effective income tax rate reconciliation, tax credit, amount mean?
The total value of tax credits applied to reduce the company's income tax liability, such as research and development or investment credits. This metric highlights the company's ability to utilize government incentives to lower its cash tax obligations.